Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current state of CAR-T therapy for T-cell malignancies.
Luo L, Zhou X, Zhou L, Liang Z, Yang J, Tu S, Li Y. Luo L, et al. Among authors: liang z. Ther Adv Hematol. 2022 Dec 26;13:20406207221143025. doi: 10.1177/20406207221143025. eCollection 2022. Ther Adv Hematol. 2022. PMID: 36601636 Free PMC article. Review.
Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome.
Tu S, Huang R, Guo Z, Deng L, Song C, Zhou X, Yue C, Zhang L, He Y, Yang J, Liang Z, Du J, Cao P, Li Y, Chang LJ, Li Y. Tu S, et al. Among authors: liang z. Am J Hematol. 2019 Dec;94(12):E322-E325. doi: 10.1002/ajh.25630. Epub 2019 Oct 2. Am J Hematol. 2019. PMID: 31489688 Free article. Clinical Trial. No abstract available.
NeoPeptide: an immunoinformatic database of T-cell-defined neoantigens.
Zhou WJ, Qu Z, Song CY, Sun Y, Lai AL, Luo MY, Ying YZ, Meng H, Liang Z, He YJ, Li YH, Liu J. Zhou WJ, et al. Among authors: liang z. Database (Oxford). 2019 Jan 1;2019:baz128. doi: 10.1093/database/baz128. Database (Oxford). 2019. PMID: 31819989 Free PMC article.
Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
Zhou X, Tu S, Wang C, Huang R, Deng L, Song C, Yue C, He Y, Yang J, Liang Z, Wu A, Li M, Zhou W, Du J, Guo Z, Li Y, Jiao C, Liu Y, Chang LJ, Li Y. Zhou X, et al. Among authors: liang z. Front Immunol. 2020 Nov 27;11:564099. doi: 10.3389/fimmu.2020.564099. eCollection 2020. Front Immunol. 2020. PMID: 33329526 Free PMC article. Clinical Trial.
Tiam1, overexpressed in most malignancies, is a novel tumor biomarker.
Chen B, Ding Y, Liu F, Ruan J, Guan J, Huang J, Ye X, Wang S, Zhang G, Zhang X, Liang Z, Luo R, Chen L. Chen B, et al. Among authors: liang z. Mol Med Rep. 2012 Jan;5(1):48-53. doi: 10.3892/mmr.2011.612. Epub 2011 Oct 3. Mol Med Rep. 2012. PMID: 21971868
10,153 results
You have reached the last available page of results. Please see the User Guide for more information.